Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nanomedicine ; 13(7): 2209-2217, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28666950

RESUMO

This study reports proof of concept for administering compacted DNA nanoparticles (DNPs) intracerebrally as a means to protect against neurotoxin-induced neurodegeneration of dopamine (DA) neurons. In this study we used DNPs that encoded for human glial cell line-derived neurotrophic factor (hGDNF); GDNF is a potent neurotrophic factor for DA neurons. Intracerebral injections of DNPs into the striatum and/or substantia nigra were performed 1 week before treatment with a neurotoxin. We observed that the number of surviving DA cells, the density of DA fiber terminals and recovery of motor function were greater in animals injected with GDNF-encoding DNPs than in control animals receiving DNPs encoding for an inert reporter gene. The results of these studies are one of the first to demonstrate that a non-viral, synthetic nanoparticle can be used to deliver therapeutic genes to cells in the brain as a means to protect cells against neurotoxin-induced neurodegeneration.


Assuntos
DNA/administração & dosagem , DNA/genética , Neurônios Dopaminérgicos/citologia , Técnicas de Transferência de Genes , Terapia Genética , Fator Neurotrófico Derivado de Linhagem de Célula Glial/genética , Neuroproteção , Animais , Sobrevivência Celular , Modelos Animais de Doenças , Neurônios Dopaminérgicos/metabolismo , Neurônios Dopaminérgicos/patologia , Terapia Genética/métodos , Humanos , Masculino , Nanopartículas/administração & dosagem , Ratos Sprague-Dawley
2.
Hippocampus ; 20(4): 469-80, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19489004

RESUMO

The human immunodeficiency virus type 1 (HIV-1) protein transactivator of transcription (Tat) is believed to play a critical role in mediating central nervous system (CNS) pathology in pediatric HIV-1 infection. Long-term neurotoxicity was investigated in a design-based stereology study following intrahippocampal injection of Tat on postnatal day (P)10, a time period that approximates the peak in the rats' rate of brain growth and mimics clinical HIV-1 CNS infection at labor/delivery. The goal was to examine the impact of P10 intrahippocampal Tat injection on the anatomy of the adult hippocampus (5 month) to gain a better understanding about how timing of infection influences the rate of progression of pediatric HIV-1 infection [cf. Fitting et al. (2008a) Hippocampus 18:135-147]. Male P10 Sprague-Dawley rats were bilaterally injected with vehicle or one of three different doses of Tat (5, 25, or 50 mug). Unbiased stereological estimates were used to quantify total neuron number (Nissl stain) in five major subregions of the rat hippocampus: granular layer (GL), hilus of the dentate gyrus (DGH), cornu ammonis fields (CA)2/3, CA1, and subiculum (SUB). Glial cells (astrocytes and oligodendrocytes) were quantified in the DGH and SUB. No significant reduction of neuron number was noted for any of the five hippocampal subregions, in contrast to the very prominent reductions reported when Tat was administered on P1 [Fitting et al. (2008a) Hippocampus 18:135-147]. However, for glial cells, the number of astrocytes in the DGH and SUB as well as the number of oligodendrocytes in the DGH were linear dose dependently increased as a function of dose of Tat. In conjunction with previous stereological research [Fitting et al., (2008a) Hippocampus 18:135-147], the present data suggest that variability in the progression of pediatric HIV/acquired immunodeficiency syndrome (AIDS) may be better understood with the knowledge of the factor of timing of HIV-1 CNS infection.


Assuntos
Astrócitos/virologia , Hipocampo/virologia , Neurônios/virologia , Oligodendroglia/virologia , Produtos do Gene tat do Vírus da Imunodeficiência Humana/administração & dosagem , Análise de Variância , Animais , Astrócitos/patologia , Contagem de Células , Relação Dose-Resposta Imunológica , Hipocampo/patologia , Masculino , Neurônios/patologia , Oligodendroglia/patologia , Ratos , Ratos Sprague-Dawley , Tempo , Produtos do Gene tat do Vírus da Imunodeficiência Humana/genética
3.
Hippocampus ; 18(2): 135-47, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-17924522

RESUMO

The human immunodeficiency virus type 1 (HIV-1) proteins, gp120 and Tat, are believed to play a role in mediating central nervous system (CNS) pathology in HIV-1 infected patients. Using design-based stereology, we examined the role of neonatal intrahippocampal injections of gp120 and Tat on the adult hippocampus ( approximately 7(1/2) month). Postnatal day (P)1-treated Sprague-Dawley rats were bilaterally injected with vehicle (VEH, 0.5 microl sterile buffer), gp120 (100 ng), Tat (25 microg) or combined gp120 + Tat (100 ng + 25 microg). Using Nissl-stained tissue sections, we quantified total neurons in five subregions of the rat hippocampus [granual layer (GL), hilus of the dentate gyrus (DGH), cornu ammonis fields (CA)2/3, CA1, and subiculum (SUB)], and total glial cells (astrocytes and oligodendrocytes) in two subregions (DGH and SUB). Estimates of cell area and cell volume were taken in the DGH. There was a significant reduction of neuron number in the CA2/3 subfield by Tat and gp120, and a significant reduction in the DGH by Tat only. For glial cells, numbers of astrocytes in the DGH and SUB were increased by the Tat protein, whereas no effects were noted for gp120. Finally, for oligodendrocytes Tat increased cell number in the DGH but not in any other region; gp120 had no detectable effect in any brain region. Estimates of cell area and cell volume of the three different cell types revealed no significant differences between treatments. Collectively, these results suggest differential effects of gp120 and Tat on the estimated total number of neurons, as well as on the number of glial cells.


Assuntos
Proteína gp120 do Envelope de HIV/toxicidade , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Produtos do Gene tat do Vírus da Imunodeficiência Humana/toxicidade , Animais , Animais Recém-Nascidos , Astrócitos/efeitos dos fármacos , Astrócitos/patologia , Contagem de Células , Feminino , Microinjeções , Neurônios/efeitos dos fármacos , Neurônios/patologia , Oligodendroglia/efeitos dos fármacos , Oligodendroglia/patologia , Gravidez , Ratos , Ratos Sprague-Dawley
4.
Int J Dev Neurosci ; 25(7): 445-54, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17933484

RESUMO

The extent of catecholaminergic receptor and respective behavioral alterations associated with prenatal cocaine exposure varies according to exogenous factors such as the amount, frequency, and route of maternal exposure, as well as endogenous factors such as specific brain regions under consideration and sex of the species. The goal of the current study was to use autoradiography to delineate possible moderators of dopaminergic and adrenergic receptor expression in adult rat offspring exposed to cocaine in utero. The current study demonstrated sex-dependent D1 receptor, alpha2, and noradrenergic transporter binding alterations in prelimbic, hippocampus, and anterior cingulate regions of adult rat brains exposed to cocaine during gestational days 8-21. Of further interest was the lack of alterations in the nucleus accumbens for nearly all receptors/transporters investigated, as well as the lack of alterations in D3 receptor binding in nearly all of the regions investigated (nucleus accumbens, prelimbic region, hippocampus, and cingulate gyrus). Thus, the current investigation demonstrated persistent receptor and transporter alterations that extend well into adulthood as a result of cocaine exposure in utero. Furthermore, the demonstration that sex played a mediating role in prenatal cocaine-induced, aberrant receptor/transporter expression is of primary importance for future studies that seek to control for sex in either design or analysis.


Assuntos
Cocaína/farmacologia , Inibidores da Captação de Dopamina/farmacologia , Efeitos Tardios da Exposição Pré-Natal , Receptores Adrenérgicos/biossíntese , Receptores Dopaminérgicos/biossíntese , Agonistas alfa-Adrenérgicos , Animais , Autorradiografia , Comportamento Animal/efeitos dos fármacos , Benzazepinas , Química Encefálica/efeitos dos fármacos , Clonidina , Antagonistas de Dopamina , Proteínas da Membrana Plasmática de Transporte de Dopamina/metabolismo , Feminino , Fluoxetina/análogos & derivados , Gravidez , Ratos , Ratos Sprague-Dawley , Receptores Adrenérgicos/efeitos dos fármacos , Receptores Adrenérgicos alfa 2/biossíntese , Receptores Dopaminérgicos/efeitos dos fármacos , Receptores de Dopamina D2/efeitos dos fármacos , Receptores de Dopamina D3/efeitos dos fármacos , Caracteres Sexuais , Tetra-Hidronaftalenos
5.
Int J Dev Neurosci ; 24(5): 335-41, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16814973

RESUMO

We examined cell minicolumns, apical dendrite bundles, and inhibitory interneurons, in prefrontal and somatosensory cortex of 21-day-old rat brains exposed to cocaine during fetal development. Cell columns and apical dendrite bundles were found to be narrower, or closer together, in all three areas following in utero cocaine exposure. The inter-rater reliability among different observers was R(2)=0.89. The number of cells stained for glutamic acid decarboxylase (GAD) was not significantly different in the prenatal cocaine exposed group compared to saline controls. The present data suggests that recreational doses of cocaine administered intravenously in early pregnancy, have the capacity to modify the maturation of the ontogenetic cell column.


Assuntos
Encéfalo/efeitos dos fármacos , Encéfalo/patologia , Cocaína/toxicidade , Neurônios/efeitos dos fármacos , Neurônios/patologia , Efeitos Tardios da Exposição Pré-Natal/patologia , Animais , Encéfalo/anormalidades , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Transtornos Relacionados ao Uso de Cocaína/complicações , Transtornos Relacionados ao Uso de Cocaína/patologia , Transtornos Relacionados ao Uso de Cocaína/fisiopatologia , Dendritos/efeitos dos fármacos , Dendritos/patologia , Modelos Animais de Doenças , Feminino , Glutamato Descarboxilase/metabolismo , Injeções Intravenosas , Masculino , Malformações do Sistema Nervoso/induzido quimicamente , Malformações do Sistema Nervoso/patologia , Malformações do Sistema Nervoso/fisiopatologia , Vias Neurais/anormalidades , Vias Neurais/efeitos dos fármacos , Vias Neurais/patologia , Gravidez , Efeitos Tardios da Exposição Pré-Natal/fisiopatologia , Ratos , Ratos Sprague-Dawley , Ácido gama-Aminobutírico/biossíntese
6.
Pharmacol Biochem Behav ; 84(2): 189-96, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16790267

RESUMO

The presence of human immunodeficiency virus (HIV-1) in the brain mediates the pathogenesis of HIV-associated dementia complex (HAD), partially through the viral toxins gp120 and Tat. This study characterized potential deficits in sensorimotor gating, as measured by prepulse inhibition (PPI), following hippocampal administration of Tat. Adult, male Sprague-Dawley rats were bilaterally injected with 50 microg Tat or saline (1 microl volume), into the hippocampus. Following 7 weeks of recovery, all animals were tested using the auditory startle response (ASR) with habituation, control, and PPI trials. Assessment of ASR habituation [100dB(A) white noise stimulus, 70dB(A) background, 5-min acclimation period, 36 habituation trials with fixed interstimulus interval (ISI) of 10 s] demonstrated a significant approximately 50% reduction in the overall peak ASR amplitude, but no change in peak ASR latency, nor an effect on the rate of habituation. PPI measures demonstrated robust alterations in sensorimotor gating. The PPI test (ISI of 0, 8, 40, 80, 120, or 4000 ms, 6-trial blocks, Latin-square) showed an attenuated response on peak ASR amplitude during the control trials (0 and 4000 ms ISI), but not on the PPI trials (8-120 ms ISI). Most striking was the rightward shift in ISI for maximal inhibition of the response (chi2(1)=4.7, p

Assuntos
Produtos do Gene tat/farmacologia , Hipocampo/efeitos dos fármacos , Inibição Psicológica , Reflexo de Sobressalto/efeitos dos fármacos , Estimulação Acústica , Animais , Habituação Psicofisiológica/efeitos dos fármacos , Masculino , Ratos , Ratos Sprague-Dawley
7.
Pharmacol Biochem Behav ; 78(3): 581-92, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15251267

RESUMO

The present study examined the sex-dependent expression of behavioral sensitization as well as changes of dopamine (DA) transporters and D1, D2, and D3 receptors following repeated intravenous nicotine administration. Male and female Sprague-Dawley rats were implanted with indwelling jugular catheters, equipped with subcutaneous intravenous injection ports. Rats were habituated to activity chambers for 3 days and were subsequently administered 15-s bolus injections of intravenous nicotine (50 microg/kg/ml) 1/day for 21 days. Animals were placed in activity chambers for 60 min immediately after the 1st and 21st nicotine injection. Observational time sampling was also performed. Brains were subsequently removed and frozen for autoradiographic DA transporter/DA receptor analysis on the afternoon females were in proestrus. With one exception, no robust sex differences were observed for locomotor activity or any rearing measures either during baseline or after initial nicotine injection. Females exhibited markedly more behavioral sensitization of locomotor activity, rearing, duration of rearing, and incidence of observed rearing. There were no sex differences in the number of D1 or D2 receptors. Females exhibited an increased number of DA transporters and decreased D3 receptors in the NAcc, relative to males. Multiple regression analyses suggest that D3 receptors and DA transporters in various striatal and NAcc subregions differentially predicted nicotine-induced behaviors for males and females. Collectively, these findings demonstrate that repeated intravenous nicotine produces sex differences in the expression of behavioral sensitization, and suggest that nicotine-induced changes of DA transporters and D3 receptors are partly responsible for increased behavioral sensitization in female rats.


Assuntos
Comportamento Animal/efeitos dos fármacos , Nicotina/farmacologia , Receptores Dopaminérgicos/análise , Animais , Autorradiografia , Proteínas da Membrana Plasmática de Transporte de Dopamina , Feminino , Injeções Intravenosas , Masculino , Glicoproteínas de Membrana/análise , Proteínas de Membrana Transportadoras/análise , Atividade Motora/efeitos dos fármacos , Proteínas do Tecido Nervoso/análise , Nicotina/administração & dosagem , Ratos , Ratos Sprague-Dawley , Receptores de Dopamina D1/análise , Receptores de Dopamina D2/análise , Receptores de Dopamina D3 , Análise de Regressão , Caracteres Sexuais
8.
Brain Res ; 987(1): 1-9, 2003 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-14499939

RESUMO

HIV-1 transactivating protein Tat is neurotoxic and is believed to play a role in the development of AIDS-associated dementia complex. Neurotoxicity of Tat may be associated with oxidative stress. In this study we examined temporal progression of histopathological changes induced by a single microinjection of Tat 1-72 into the rat striatum. Degenerating neural cells, detected by Fluoro-Jade B staining and increased protein oxidation, determined by protein carbonyl immunostaining, were observed in the striatum as soon as 2 h following the microinjection. Further progression of neuronal degeneration was associated with pronounced infiltration of the area surrounding Tat 1-72 injection site by OX-42 positive macrophages/microglia, which was evident at the 24 h time point. Signs of reactive astrocytosis were found in the striatum of Tat 1-72 injected animals as late as 7 days following the single microinjection. Increased GFAP immunoreactivity and changes in the morphology of astrocytes coincided with a second phase of increased protein carbonyl formation, but not with neuronal degeneration. Control polypeptide, nontoxic Tat delta 31-61, did not cause any cell death, inflammatory reaction or oxidative damage. Results of our study support the hypothesis that oxidative stress may be an early step in the mechanism of Tat neurotoxicity.


Assuntos
Acetiltransferases/toxicidade , Antígenos CD , Antígenos de Neoplasias , Antígenos de Superfície , Proteínas Aviárias , Proteínas Sanguíneas , Corpo Estriado/metabolismo , Gliose/virologia , Infecções por HIV/metabolismo , HIV-1 , Glicoproteínas de Membrana/metabolismo , Degeneração Neural , Acetiltransferases/administração & dosagem , Animais , Basigina , Gliose/metabolismo , Histona Acetiltransferases , Immunoblotting , Imuno-Histoquímica , Lisina Acetiltransferase 5 , Macrófagos/metabolismo , Masculino , Microglia/metabolismo , Estresse Oxidativo , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...